Optimizing Timelines for Diagnostic & CDx Payer Outreach & Launch
Recorded on June 3, 2021
Dana Dilbeck, Senior Director, Market Access, Reimbursement and Pricing – Diagnostics and Genomics Group, Agilent Technologies, Inc.
In the increasingly competitive diagnostic marketplace, products are often brought to payers prematurely in order to reach the market more quickly. When research is less substantial, however, damaged payer perception can extend to the larger diagnostic industry. This presentation explores how to successfully balance the need for rigorous research with the urgency of connecting with payers early in the development process, crafting a cohesive reimbursement strategy. The review will be looking at timelines and paths for Laboratory Developed Test (LDT) and Companion Diagnostics (CDx) entering the market.
This webinar is available to single attendees for $249. Group discounts are available.
Payer Relations/Payer Policy